| Dr Elena R Dailey, MD | |
|
4300 Londonderry Rd, Harrisburg, PA 17109-5317 | |
| (717) 231-8772 | |
| (717) 231-8435 |
| Full Name | Dr Elena R Dailey |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 20 Years |
| Location | 4300 Londonderry Rd, Harrisburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063627784 | NPI | - | NPPES |
| 102209804 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD433695 (Pennsylvania) | Secondary |
| 207R00000X | Internal Medicine | MD433695 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carlisle Regional Medical Center | Carlisle, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pinnacle Health Hospitalist Services Llc | 9739313545 | 175 |
News Archive
New study findings show that exposure to on-screen smoking in movies has a strong correlation with beginning to smoke or becoming established smokers among young adults 18-25, a critical age group for lifelong smoking behavior.
Almost 1 in 6 of the millions of Americans on the new blood-thinning medications for atrial fibrillation, a common heart condition characterized by an irregular and often rapid heart rate, may not be receiving the recommended dose, new Mayo Clinic research finds.
Thousands of physicians, researchers and academics from around the world will gather in New Orleans in early May for Digestive Disease Week- (DDW-), the premiere scientific conference in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
Esperance Pharmaceuticals Inc. today reported positive results from a Phase II trial of lead candidate EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 is a targeted membrane-disrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers.
› Verified 2 days ago
| Entity Name | Pinnacle Health Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932143427 PECOS PAC ID: 7618960493 Enrollment ID: O20040407000180 |
News Archive
New study findings show that exposure to on-screen smoking in movies has a strong correlation with beginning to smoke or becoming established smokers among young adults 18-25, a critical age group for lifelong smoking behavior.
Almost 1 in 6 of the millions of Americans on the new blood-thinning medications for atrial fibrillation, a common heart condition characterized by an irregular and often rapid heart rate, may not be receiving the recommended dose, new Mayo Clinic research finds.
Thousands of physicians, researchers and academics from around the world will gather in New Orleans in early May for Digestive Disease Week- (DDW-), the premiere scientific conference in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
Esperance Pharmaceuticals Inc. today reported positive results from a Phase II trial of lead candidate EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 is a targeted membrane-disrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers.
› Verified 2 days ago
| Entity Name | Pinnacle Health Hospitalist Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023458148 PECOS PAC ID: 9739313545 Enrollment ID: O20131010001079 |
News Archive
New study findings show that exposure to on-screen smoking in movies has a strong correlation with beginning to smoke or becoming established smokers among young adults 18-25, a critical age group for lifelong smoking behavior.
Almost 1 in 6 of the millions of Americans on the new blood-thinning medications for atrial fibrillation, a common heart condition characterized by an irregular and often rapid heart rate, may not be receiving the recommended dose, new Mayo Clinic research finds.
Thousands of physicians, researchers and academics from around the world will gather in New Orleans in early May for Digestive Disease Week- (DDW-), the premiere scientific conference in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
Esperance Pharmaceuticals Inc. today reported positive results from a Phase II trial of lead candidate EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 is a targeted membrane-disrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers.
› Verified 2 days ago
| Entity Name | Pinnacle Health Regional Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013441690 PECOS PAC ID: 7416228358 Enrollment ID: O20170810001731 |
News Archive
New study findings show that exposure to on-screen smoking in movies has a strong correlation with beginning to smoke or becoming established smokers among young adults 18-25, a critical age group for lifelong smoking behavior.
Almost 1 in 6 of the millions of Americans on the new blood-thinning medications for atrial fibrillation, a common heart condition characterized by an irregular and often rapid heart rate, may not be receiving the recommended dose, new Mayo Clinic research finds.
Thousands of physicians, researchers and academics from around the world will gather in New Orleans in early May for Digestive Disease Week- (DDW-), the premiere scientific conference in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
Esperance Pharmaceuticals Inc. today reported positive results from a Phase II trial of lead candidate EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 is a targeted membrane-disrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elena R Dailey, MD 4300 Londonderry Rd, Harrisburg, PA 17109-5317 Ph: () - | Dr Elena R Dailey, MD 4300 Londonderry Rd, Harrisburg, PA 17109-5317 Ph: (717) 231-8772 |
News Archive
New study findings show that exposure to on-screen smoking in movies has a strong correlation with beginning to smoke or becoming established smokers among young adults 18-25, a critical age group for lifelong smoking behavior.
Almost 1 in 6 of the millions of Americans on the new blood-thinning medications for atrial fibrillation, a common heart condition characterized by an irregular and often rapid heart rate, may not be receiving the recommended dose, new Mayo Clinic research finds.
Thousands of physicians, researchers and academics from around the world will gather in New Orleans in early May for Digestive Disease Week- (DDW-), the premiere scientific conference in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
Esperance Pharmaceuticals Inc. today reported positive results from a Phase II trial of lead candidate EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 is a targeted membrane-disrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers.
› Verified 2 days ago
Lindsey Marie Govern, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 810 Sir Thomas Ct Ste 101, Harrisburg, PA 17109 Phone: 717-614-4420 Fax: 717-614-4421 | |
Quan Tran, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 S Front St, Harrisburg, PA 17101 Phone: 717-231-8772 | |
Richard Haley Jeffries, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4830 Londonderry Rd, Harrisburg, PA 17109 Phone: 717-657-2595 Fax: 717-657-3091 | |
Joanne G Gordon, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 111 S Front St, Harrisburg, PA 17101 Phone: 717-782-3380 Fax: 717-782-5716 | |
Dr. David Edward Dudick, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 111 S Front St, Internal Medicine Residency Program, Brady Hall 3, Harrisburg, PA 17101 Phone: 717-782-3131 | |
Emily Ramasra, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 S Front St, Harrisburg, PA 17101 Phone: 717-231-8506 | |
Mr. Siddharth Goel, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 205 S Front St Upmc Pinnacle, Internal Medicine Residen, Suite 3c, Harrisburg, PA 17104 Phone: 717-231-8506 Fax: 717-231-8535 |